Yinglan Jin

787 total citations
19 papers, 671 citations indexed

About

Yinglan Jin is a scholar working on Molecular Biology, Cancer Research and Hematology. According to data from OpenAlex, Yinglan Jin has authored 19 papers receiving a total of 671 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 8 papers in Cancer Research and 4 papers in Hematology. Recurrent topics in Yinglan Jin's work include Cancer, Hypoxia, and Metabolism (5 papers), ATP Synthase and ATPases Research (3 papers) and Bioactive natural compounds (3 papers). Yinglan Jin is often cited by papers focused on Cancer, Hypoxia, and Metabolism (5 papers), ATP Synthase and ATPases Research (3 papers) and Bioactive natural compounds (3 papers). Yinglan Jin collaborates with scholars based in South Korea and China. Yinglan Jin's co-authors include Kyeong Lee, Young‐Soo Hong, Navneet Kaur, Jung Joon Lee, Xuejun Jin, Shanthaveerappa K. Boovanahalli, Jin Hwan Kim, Jeong Hyun Lee, Yan Xia and Yongseok Choi and has published in prestigious journals such as Blood, Chemical Communications and Biochemical and Biophysical Research Communications.

In The Last Decade

Yinglan Jin

19 papers receiving 665 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yinglan Jin South Korea 14 406 284 153 72 58 19 671
Ruth Freeman Australia 10 562 1.4× 334 1.2× 90 0.6× 115 1.6× 22 0.4× 10 823
Xianling Ning China 13 374 0.9× 168 0.6× 169 1.1× 70 1.0× 30 0.5× 29 607
Olesya A. Ulanovskaya United States 15 636 1.6× 139 0.5× 233 1.5× 134 1.9× 48 0.8× 18 925
Guangyue Li China 18 786 1.9× 146 0.5× 80 0.5× 118 1.6× 42 0.7× 37 1.0k
Caroline Ballot France 13 299 0.7× 108 0.4× 155 1.0× 68 0.9× 18 0.3× 21 662
Michelle Helen Visagie South Africa 15 401 1.0× 185 0.7× 110 0.7× 120 1.7× 20 0.3× 33 698
Yuyan Bao China 12 273 0.7× 99 0.3× 111 0.7× 56 0.8× 44 0.8× 22 579
Hea-Young Park Choo South Korea 13 278 0.7× 121 0.4× 278 1.8× 72 1.0× 45 0.8× 20 632
Michael H. Rabinowitz United States 17 385 0.9× 256 0.9× 545 3.6× 64 0.9× 51 0.9× 29 1.1k
Santiago Díaz‐Moralli Spain 10 445 1.1× 222 0.8× 46 0.3× 139 1.9× 29 0.5× 11 679

Countries citing papers authored by Yinglan Jin

Since Specialization
Citations

This map shows the geographic impact of Yinglan Jin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yinglan Jin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yinglan Jin more than expected).

Fields of papers citing papers by Yinglan Jin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yinglan Jin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yinglan Jin. The network helps show where Yinglan Jin may publish in the future.

Co-authorship network of co-authors of Yinglan Jin

This figure shows the co-authorship network connecting the top 25 collaborators of Yinglan Jin. A scholar is included among the top collaborators of Yinglan Jin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yinglan Jin. Yinglan Jin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Zhao, Weiwei, Juan Liu, Liyan Chen, et al.. (2024). Efficacy and Safety of Carfilzomib-Based Regiments for the Treatment of Relapsed or Refractory Multiple Myeloma: Single-Center Real-Word Data. Blood. 144(Supplement 1). 7024–7024. 1 indexed citations
2.
3.
Gao, Xinyu, et al.. (2021). Mechanism of exosomal miR-155 derived from bone marrow mesenchymal stem cells on stemness maintenance and drug resistance in myeloma cells. Journal of Orthopaedic Surgery and Research. 16(1). 637–637. 21 indexed citations
4.
Gao, Haiyan, Yongfang Jiang, Yinglan Jin, et al.. (2015). Suppression of HSP27 increases the anti-tumor effects of quercetin in human leukemia U937 cells. Molecular Medicine Reports. 13(1). 689–696. 50 indexed citations
5.
Zhang, Xiaomin, Xi Chen, Juan Liu, et al.. (2015). Knockdown of WISP1 inhibit proliferation and induce apoptosis in ALL Jurkat cells.. PubMed. 8(11). 15489–96. 8 indexed citations
6.
Shi, Jialan, Jin Zhou, Yinglan Jin, et al.. (2013). Chemotherapy induces enhanced procoagulant activity through phosphatidylserine exposure in acute lymphoblastic leukemia. Thrombosis Research. 132(5). 614–620. 9 indexed citations
7.
Wang, Jinghua, Xin Yan, Yanming Xue, et al.. (2013). Heparin-Induced Thrombocytopenia in Chinese Patients: 240 Patients Study in One Center. Clinical Laboratory. 59(07+08/2013). 735–40. 1 indexed citations
8.
Xia, Yan, Yinglan Jin, Navneet Kaur, Yongseok Choi, & Kyeong Lee. (2011). HIF-1α inhibitors: Synthesis and biological evaluation of novel moracin O and P analogues. European Journal of Medicinal Chemistry. 46(6). 2386–2396. 47 indexed citations
9.
Lee, Kyeong, Song‐Kyu Park, Yinglan Jin, et al.. (2010). LW6, a novel HIF-1 inhibitor, promotes proteasomal degradation of HIF-1α via upregulation of VHL in a colon cancer cell line. Biochemical Pharmacology. 80(7). 982–989. 126 indexed citations
10.
Min, Kyung Hoon, Eun‐Kyung Kim, Yinglan Jin, et al.. (2009). A novel class of highly potent multidrug resistance reversal agents: Disubstituted adamantyl derivatives. Bioorganic & Medicinal Chemistry Letters. 19(18). 5376–5379. 13 indexed citations
11.
Won, Misun, Soo-Hyun Park, Shanthaveerappa K. Boovanahalli, et al.. (2009). A novel benzimidazole analogue inhibits the hypoxia-inducible factor (HIF)-1 pathway. Biochemical and Biophysical Research Communications. 385(1). 16–21. 51 indexed citations
12.
Kaur, Navneet, Yan Xia, Yinglan Jin, et al.. (2009). The first total synthesis of moracin O and moracin P, and establishment of the absolute configuration of moracin O. Chemical Communications. 1879–1879. 37 indexed citations
13.
Jin, Yinglan. (2009). Synthesis of a Novel Series of Imidazo[1,2-α]pyridines as Acyl-CoA: Cholesterol Acyltransferase (ACAT) Inhibitors. Bulletin of the Korean Chemical Society. 30(6). 1297–1304. 25 indexed citations
14.
Zhang, Zongfeng, Tiefang Song, Yinglan Jin, et al.. (2009). Epidermal Growth Factor Receptor Regulates MT1-MMP and MMP-2 Synthesis in SiHa Cells via Both PI3-K/AKT and MAPK/ERK Pathways. International Journal of Gynecological Cancer. 19(6). 998–1003. 22 indexed citations
15.
Kaur, Navneet, Yan Xia, Yinglan Jin, et al.. (2009). ChemInform Abstract: The First Total Synthesis of Moracin O and Moracin P, and Establishment of the Absolute Configuration of Moracin O.. ChemInform. 40(34). 1 indexed citations
16.
Boovanahalli, Shanthaveerappa K., Xuejun Jin, Yinglan Jin, et al.. (2007). Synthesis of (aryloxyacetylamino)-isonicotinic/nicotinic acid analogues as potent hypoxia-inducible factor (HIF)-1α inhibitors. Bioorganic & Medicinal Chemistry Letters. 17(22). 6305–6310. 28 indexed citations
17.
Lee, Kyeong, Jung Su Ryu, Yinglan Jin, et al.. (2007). Synthesis and anticancer activity of geldanamycin derivatives derived from biosynthetically generated metabolites. Organic & Biomolecular Chemistry. 6(2). 340–348. 29 indexed citations
18.
Song, Eun Young, Navneet Kaur, Yinglan Jin, et al.. (2007). Synthesis of amide and urea derivatives of benzothiazole as Raf-1 inhibitor. European Journal of Medicinal Chemistry. 43(7). 1519–1524. 62 indexed citations
19.
Lee, Kyeong, Jeong Hyun Lee, Shanthaveerappa K. Boovanahalli, et al.. (2007). (Aryloxyacetylamino)benzoic Acid Analogues:  A New Class of Hypoxia-Inducible Factor-1 Inhibitors. Journal of Medicinal Chemistry. 50(7). 1675–1684. 121 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ruth Freeman Breakdown of academic impact, for papers by Xianling Ning Breakdown of academic impact, for papers by Olesya A. Ulanovskaya Breakdown of academic impact, for papers by Guangyue Li Breakdown of academic impact, for papers by Caroline Ballot Breakdown of academic impact, for papers by Michelle Helen Visagie Breakdown of academic impact, for papers by Yuyan Bao Breakdown of academic impact, for papers by Hea-Young Park Choo Breakdown of academic impact, for papers by Michael H. Rabinowitz Breakdown of academic impact, for papers by Santiago Díaz‐Moralli
Rankless by CCL
2026